Karyopharm Therapeutics

310 articles with Karyopharm Therapeutics

• Karyopharm Therapeutics To Report Fourth Quarter And Full Year 2014 Financial Results On March 16, 2015

  3/9/2015

• Nature Neuroscience Publishes Data Demonstrating Potential Therapeutic Benefits Of Karyopharm Therapeutics's SINE Compounds In The Treatment Of Multiple Sclerosis

  2/24/2015

• Karyopharm Therapeutics To Present At Leerink Partners Global Healthcare Conference

  2/5/2015

• Karyopharm Therapeutics To Present At J.P. Morgan 33rd Annual Healthcare Conference

  1/8/2015

• Karyopharm Therapeutics Announces Orphan Designation Granted By FDA For Selinexor (KPT-330) In Multiple Myeloma

  1/8/2015

• Karyopharm Therapeutics Announces Pricing Of Public Offering Of Common Stock

  1/7/2015

• Karyopharm Therapeutics Announces Proposed Public Offering Of Common Stock

  1/6/2015

• Karyopharm Therapeutics Announces Addition To The NASDAQ Biotechnology Index

  12/15/2014

• Karyopharm Therapeutics Initiates Third Registration-Directed Clinical Trial Of Oral Selinexor (KPT-330)

  12/11/2014

• Karyopharm Therapeutics Presents Positive Combination Data For Selinexor (KPT-330) In Multiple Myeloma Patients At American Society of Hematology 2014 Annual Meeting

  12/9/2014

• Karyopharm Therapeutics Presents Positive Clinical Data For Selinexor (KPT-330) In NHL Patients At American Society of Hematology 2014 Annual Meeting

  12/9/2014

• Karyopharm Therapeutics To Present At Oppenheimer 25th Annual Healthcare Conference

  12/5/2014

• Karyopharm Therapeutics Presents Data On Oncology Pipeline At EORTC-NCI-AACR Annual Meeting

  12/1/2014

• Karyopharm Therapeutics Announces Additional Orphan Designations Granted For Selinexor (KPT-330) By European Commission (EC)

  12/1/2014

• Karyopharm Therapeutics Reports Third Quarter 2014 Financial Results And Highlights Recent Progress

  11/10/2014

• Karyopharm Therapeutics Initiates Registration-Directed Clinical Study Of Selinexor (KPT-330) In Patients With Richter's Transformation

  11/10/2014

• Karyopharm Therapeutics Announces Data Presentations At American Society of Hematology Annual Meeting

  11/6/2014

• Karyopharm Therapeutics To Present At Credit Suisse 2014 Healthcare Conference

  11/5/2014

• Karyopharm Therapeutics Appoints J. Scott Garland To Its Board Of Directors

  11/4/2014

• Karyopharm Therapeutics To Report Third Quarter 2014 Financial Results On November 10, 2014

  10/30/2014